Detalles de la búsqueda
1.
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.
Cancer Immunol Immunother;
73(7): 125, 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38733402
2.
The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study.
BMC Cancer;
22(1): 505, 2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524225
3.
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study.
Cancer Cell Int;
21(1): 604, 2021 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34772421
4.
Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959).
BMC Med;
17(1): 190, 2019 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31640711
5.
Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area.
BMC Cancer;
19(1): 37, 2019 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30621619
6.
Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
Cell Physiol Biochem;
48(1): 285-292, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30011397
7.
The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.
BMC Cancer;
18(1): 740, 2018 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012115
8.
Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA.
Cancer Sci;
108(8): 1640-1647, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28603915
9.
Prognostic value of primary gross tumor volume and standardized uptake value of 18F-FDG in PET/CT for distant metastasis in locoregionally advanced nasopharyngeal carcinoma.
Tumour Biol;
39(7): 1010428317717843, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28671052
10.
Critical Evaluation of the Quality and Recommendations of Clinical Practice Guidelines for Nasopharyngeal Carcinoma.
J Natl Compr Canc Netw;
15(3): 336-344, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275034
11.
Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real-world study based on medical comorbidities.
Head Neck;
2024 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366693
12.
The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy.
Radiother Oncol;
178: 109414, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36375563
13.
Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study.
J Cancer Res Clin Oncol;
149(13): 11929-11940, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37418058
14.
Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?
J Cancer Res Clin Oncol;
148(10): 2569-2579, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618220
15.
Development of a web-based prognostic model to quantify the survival benefit of cumulative cisplatin dose during concurrent chemoradiotherapy in childhood nasopharyngeal carcinoma.
Radiother Oncol;
166: 118-125, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838885
16.
The prognostic value of adding systemic inflammation response index to Epstein-Barr virus DNA in childhood nasopharyngeal carcinoma: A real-world study.
Head Neck;
44(6): 1404-1413, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373866
17.
Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.
Cancer Res Treat;
53(3): 657-670, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285052
18.
The effect of adding concurrent chemotherapy to radiotherapy for stage II nasopharyngeal carcinoma with undetectable pretreatment Epstein-Barr virus DNA: Retrospective analysis with a large institutional-based cohort.
Transl Oncol;
14(2): 100990, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33338876
19.
Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study.
Radiother Oncol;
161: 83-91, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34116076
20.
A deep-learning-based prognostic nomogram integrating microscopic digital pathology and macroscopic magnetic resonance images in nasopharyngeal carcinoma: a multi-cohort study.
Ther Adv Med Oncol;
12: 1758835920971416, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33403013